Chigusa Morizane

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Chigusa Morizane

Aug 12, 2024, 04:06 | Blog

Akihiro Ohba: Trastuzumab Deruxtecan in HER 2–Expressing Biliary Tract Cancer

Akihiro Ohba, Medical Oncologist at Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital,…

Aug 11, 2024, 12:56 | Insight

Trastuzumab Deruxtecan in HER2–Expressing BTC - Key points by Arndt Vogel

Arndt Vogel shared a post on X: "Trastuzumab Deruxtecan in HER2–Expressing BTC published in Journal of…

Aug 9, 2024, 02:19 | Blog

Activity of T-DXd in HER2-expressing Biliary Tract Cancer

Paolo Tarantino shared on X: "Activity of T-DXd in HER2-expressing BTC published in Journal of Clinical…

Aug 7, 2024, 16:01 | Insight

Piotr Wysocki: Trastuzumab Deruxtecan Shows Promise in Treating HER2-Positive Biliary Tract Cancer

Piotr Wysocki recently shared on LinkedIn: "A recent phase II clinical trial conducted across five…

Jul 20, 2024, 10:27 | Blog

Elizabeth McKenna: The SCRUM-MONSTAR Cancer-Omics Ecosystem

Elizabeth McKenna shared a post on X: ''Now online in Cancer Discovery: The SCRUM-MONSTAR Cancer-Omics…

All: 5 Posts: 1 - 100

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

'

King Charles III Hospitalized Following Side Effects from Cancer Treatment

'

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

'

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023